azathioprine and sirolimus

azathioprine has been researched along with sirolimus in 145 studies

Research

Studies (145)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's14 (9.66)18.2507
2000's90 (62.07)29.6817
2010's39 (26.90)24.3611
2020's2 (1.38)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Kahan, BD4
Engelbrecht, ME; Myburgh, JA; Oosthuizen, MM1
Asselin, I; Guérette, B; Kinoshita, I; Lille, S; Roy, R; Tremblay, JP; Vilquin, JT1
Almond, PS; Chen, S; Matas, A; Melin, M; Moss, A; Nakhleh, R; Salazar, A; Shirabe, K1
Brattström, C; Claesson, K; Groth, CG; Herlenius, G; Säwe, J; Tydén, G1
Sayegh, MH; Vella, JP1
Aspeslet, LJ; Gallant, HL; Yatscoff, RW1
Akizuki, E; Ichiguchi, O; Liang, J; Matsuda, T; Matsumura, F; Mori, K; Ogawa, M; Ohshiro, H; Okabe, K; Yamada, S; Yamaguchi, Y1
Alho, H; Harjula, AL; Ikonen, T; Maasilta, P; Salminen, US; Taskinen, E1
Aspeslet, LJ; Yatscoff, RW1
Böttiger, Y; Brattström, C; Groth, CG; Säwe, J; Tydén, G; Wilczek, HE1
Deol, HS; Tuch, BE; Wright, DC1
Grinyó, JM1
Alho, HS; Harjula, AL; Ikonen, TS; Maasilta, PK; Salminen, US; Taskinen, EI1
Belitsky, P; Kiberd, B; Lawen, J; MacDonald, A; Mahalati, K; McAlister, V; West, K1
Gleadle, JM; Mason, PD1
Cristol, JP; Descomps, B; Dupuy, AM; Garrigue, V; Mourad, G; Tur, MD; Vela, C1
Kahan, BD; Mahalati, K1
Harjula, AL; Lautenschlager, IT; Maasilta, PK; Salminen, US; Taskinen, EI1
Ettenger, RB; Grimm, EM1
Coosemans, W; Evenepoel, P; Kuypers, DR; Maes, BD; Pirenne, J; Vanrenterghem, YF1
Bäckman, L; Burke, JT; Kreis, H; Morales, JM; Taylor, R; Wilczek, H1
Kushwaha, SS; Mayer, DF1
Bäckman, L; Brattström, C; Calne, R; Campistol, JM; Charpentier, B; Claesson, K; Durand, D; Groth, CG; Kreis, H; Lang, P; Morales, JM; Touraine, JL; Wramner, L1
Hricik, DE1
Casarini, D; Felipe, CR; Franco, M; Garcia, R; Hanzawa, NM; Hosaka, BH; Lima, VC; Machado, PG; Medina-Pestana, JO; Motegi, S; Park, SI; Tedesco Silva, H1
Avery, RK1
Abeywickrama, KH; Bernhardt, P; Dorent, R; Eisen, HJ; Hummel, M; Kobashigawa, J; Lind, JM; Mancini, D; Starling, RC; Sørensen, K; Tuzcu, EM; Valantine-von Kaeppler, HA1
Dorent, R; Eisen, H; Hsu, CH; Kovarik, JM; Mancini, D; Rordorf, C; Rouilly, M; Vigano, M1
Braun, WE1
Banas, B; Böger, C; Krämer, B1
Derweesh, I; Flechner, SM; Goldfarb, D; Krishnamurthi, V; Mastroianni, B; Modlin, CS; Novick, A; Savas, K; Zhou, L1
Pleyer, U1
Mueller, XM1
Azzola, A; Black, J; Chhajed, P; Glanville, A; Havryk, A; Hostettler, K; Johnson, P; Roth, M; Tamm, M1
Doggrell, SA1
Schulak, JA1
Eisen, H; Ross, H1
Shapiro, R1
Alfieri, F; Felipe, CR; Franco, M; Garcia, R; Hanzawa, NM; Machado, PG; Medina-Pestana, JO; Park, SI; Silva, HT1
Gentil, MA; González Roncero, FM; López, M; Martínez, M; Mateos, J; Pereira, P; Rodríguez Algarra, G; Toro, J; Valdivia, MA1
Encke, J; Sauer, P; Stremmel, W; Uhl, W1
Esmore, D; Faddy, S; Galbraith, A; Keogh, A; Macdonald, P; Muller, D; O'Driscoll, G; Richardson, M; Ruygrok, P; Spratt, P1
Lo, A1
Dorschner, L; Gallino, A; Ruschitzka, F; Seebach, JD; Speich, R1
Alfieri, F; Casarini, D; Felipe, CR; Franco, M; Garcia, R; Machado, PG; Medina-Pestana, JO; Moreira, S; Park, SI; Tedesco-Silva, H1
Kari, JA; Trompeter, RS1
McDonald, RA; Nemeth, TL; Smith, JM1
Alho, HS; Maasilta, PK; Päiväniemi, OE; Salminen, US; Wolff, CH1
Hare, JM; Hauptman, P; Kovarik, JM; Mayer, HW; McCurry, KR; Schmidli, H; Starling, RC1
Neuberger, J; Perry, I1
Kobashigawa, J; Lindenfeld, J; Lowes, BD; Mestroni, L; Miller, GG; Page, RL; Shakar, SF; Wolfel, EE; Zolty, R1
Dirks, NL; Huth, B; Meibohm, B; Yates, CR1
Cantu, E; Cretin, N; Kaló, Z; Kauf, TL; Radeva, JI; Reed, SD; Schulman, KA1
Baczkowska, T; Durlik, M1
Valantine, H; Zuckermann, A1
Valantine, H1
Dugan, C; Emre, S; Gondolesi, G; Kerkar, N; Morotti, RA; Rumbo, C; Shneider, BL1
Akiyama, Y; Aramaki, O; Ikeda, Y; Inoue, F; Kitajima, M; Matsumoto, K; Niimi, M; Shibutani, S; Shimazu, M; Shirasugi, N1
Bailey, M; Kotsimbos, TC; Law, L; Levvey, BJ; Orsida, B; Snell, GI; Whitford, HM; Williams, TJ; Zheng, L1
Kovarik, JM; Starling, RC1
González-Posada, JM; Hernández, D1
Ciancio, G; Gonwa, TA; Miller, J1
Buell, JF; Gross, TG; Woodle, ES1
Casarini, DE; Felipe, CR; Garcia, R; Machado, PG; Medina-Pestana, JO; Moreira, SR; Park, SI; Spinelli, GA; Tedesco-Silva, H1
Aris, R; Glanville, AR; Hmissi, A; Loyd, JE; McGiffin, DC; Pirron, U; Roman, A; Snell, GI; Sole, A; Valentine, VG; Vitulo, P1
Aris, R; Chan, CK; Kovarik, JM; Pirron, U; Schmidli, H; Snell, GI; Valentine, V1
Fischereder, M; Graeb, C; Jauch, KW; Kammerl, MC; Krämer, BK; Krüger, B; Zülke, C1
Calabrese, S; Sparacino, V1
Eisen, H1
Cheng, Y; Cherikh, WS; Hanto, DW; Kauffman, HM; McBride, MA1
Hoitsma, AJ; van den Akker, JM; Wetzels, JF1
Chi, NH; Chou, NK; Hsu, RB; Ko, WJ; Tsao, CI; Wang, CH; Wang, SS; Wu, FL1
Chalermsanyakorn, P; Changsirikulchai, S; Lothuvachai, T; Sumethkul, V1
Barbari, AG; Masri, MA; Stephan, AG1
Gustafsson, F; Ross, HJ1
Beaumont, BW; Copeland, JW; Merrilees, MJ; Pilmore, HL1
Benavente, D; Buckel, E; Contreras, L; Ferrario, M; Fierro, A; Herzog, C; Morales, J; Zehnder, C1
Carreño, CA; Gadea, M1
Abeywickrama, K; Benza, R; Boissonnat, P; Cretin, N; Eisen, HJ; Haverich, A; Hill, J; Laufer, G; Love, R; Parameshwar, J; Pulpón, LA; Renlund, D; Starling, RC; Tuzcu, M; Viganò, M1
Bailey, M; Kotsimbos, TC; Levvey, BJ; Orsida, B; Snell, GI; Williams, TJ; Zheng, L1
Járay, J; Kahan, BD; Langer, R; Máthé, Z; Remport, A; Tóth, A1
Snell, GI; Westall, GP1
Bae, JH; Clavell, AL; Edwards, BS; Frantz, RP; Khalpey, Z; Kremers, WK; Kushwaha, SS; Lerman, A; Raichlin, E; Rihal, C; Rodeheffer, RJ1
Mudge, GH1
Abbott, KC; Axelrod, D; Brennan, DC; Buchanan, PM; Burroughs, TE; Dzebisashvili, N; Lentine, KL; Salvalaggio, PR; Schnitzler, MA; Willoughby, LM1
Almeida, JM; Ikeda, MY; Saber, LT1
Annemans, L; Hetzer, R; Lemkuhl, H; Ricci, JF; Schulz, U; Tenderich, G; Yang, XL1
Armstrong, VW; Brandhorst, G; Koerfer, R; Oellerich, M; Oezpeker, C; Tenderich, G; Zittermann, A1
Campbell, S; Chadban, SJ; Chang, SH; McDonald, SP; Russ, GR1
Adamkovic, AB; Blum, MD; Caulfield, ME; Demopoulos, LA; Hembekides, DD; Rothrock, LC; Schubert, CM; Singh, AB; Steele, GH1
Anglicheau, D; Beaune, P; Legendre, C; Thervet, E1
Alexeeva, O; Feagan, B; Haas, T; Korom, S; Lémann, M; Mayer, H; Mikhailova, T; Panés, J; Reinisch, W; Sanna, L; Schmidt, S; Schreiber, S; Sturniolo, GC1
de Prada, JA; Exposito, V; Fernández-Friera, L; García-Camarero, T; González-Vílchez, F; Llano, M; Martín-Durán, R; Ruano, J1
El-Agroudy, AE; El-Dahshan, KF; Gad, ZA; Ghoneim, MA; Ismail, AM; Sheashaa, HA; Shokeir, AA; Wafa, EW1
Hu, XP; Ma, LL; Wang, W; Wang, Y; Yang, XY; Yin, H; Zhang, XD1
Baran, D; Birnbaum, LM; Cantarovich, M; Chaudhury, P; Herrera-Gayol, A; Lipman, M; Paraskevas, S; Tchervenkov, J1
Coelho, LG; Lasmar, EP; Lasmar, LF; Lasmar, MF; Lima, PV; Nogueira, AF1
Abraham, M; Al-Muzairai, I; Al-Otaibi, T; Al-Waheeb, S; Balaha, MA; Halim, MA; Hamid, MH; Johny, KV; Nair, MP; Nampoory, MR; Said, T; Tawab, KA1
Badiwala, M; Prodger, J; Ramzy, D; Raoa, V; Ross, H; Sheshgiri, R; Tepperman, E1
Davaus Gasparetto, T; Marchiori, E; Menezes, P; Zanetti, G1
Fischer, L; Nashan, B; Schaefer, H; Staufer, K; Sterneck, M1
Balal, M; Binokay, F; Demir, E; Erken, U; Kurt, C; Paydas, S; Sertdemir, Y; Sikgenc, MM1
Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; Deoliveira, NC; Durazo-Arvizu, R; Garrity, E; Husain, A; Krishnan, JA; Love, RB; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT1
Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; DeOliveira, NC; Durazo-Arvizu, R; Garrity, E; Krishnan, JA; Love, RB; McShane, PJ; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT1
Celik, S; Dengler, TJ; Doesch, AO; Ehlermann, P; Frankenstein, L; Katus, HA; Konstandin, M; Kristen, A; Müller, S; Sack, FU1
Chen, H; Egan, JJ1
Kobashigawa, JA; Patel, JK1
Arora, S; Aukrust, P; Bendz, B; Bøtker, HE; Eiskjær, H; Ekmehag, B; Gude, E; Gullestad, L; Jansson, K; Mortensen, SA; Saunamaki, K; Sigurdadottir, V; Simonsen, S; Solbu, D; Ueland, T; Wennerblom, B1
Arizon, JM; Barten, MJ; Dong, G; Eisen, HJ; Kobashigawa, J; Lehmkuhl, H; Pelligrini, C; Ross, H; Wang, SS; Zuckermann, A1
Mishra, OP; Mittal, R; Prasad, R; Singh, UK1
Ghoneim, MA; Ismail, AM; Kamal, AI; Mahmoud, KM; Refaie, AF; Sheashaa, HA1
Lee, EK; Mao, PC; Tseng, PL1
Cheng, CY; Shu, KH; Tsai, SF; Wu, MJ1
Alonso, EM; Ekong, UD; Mathew, J; Melin-Aldana, H; Wang, D1
Bootun, R1
Gossmann, J; Graff, J; Harder, S; Reiche, C; Scheuermann, EH1
Bara, C; Delgado, JF; Dengler, T; Dong, G; Junge, G; Kobashigawa, J; Lehmkuhl, HB; Potena, L; Ross, H; Wang, SS; Witte, S1
Chan, AJ; Lake, JR1
Wagner, JA1
Carroll, RP; Harden, PN; Hester, J; Wood, KJ1
Bröker, BM; Brunner-Weinzierl, MC; Dummer, A; Evert, M; Fitzner, B; Jaster, R; Kraatz, F; Lerch, MM; Mayerle, J; Nizze, H; Salem, T; Schwaiger, T; van den Brandt, C; Wartmann, T; Zaatreh, S1
Agena, F; Azevedo, LS; David-Neto, E; Gamba, C; Gerhard, J; Miraglia, JL; Pierrotti, L; Precioso, AR; Shikanai Yasuda, MA; Tavares Timenetsky, MD1
Aleksić, P; Drasković-Pavlović, B; Dujić, A; Hrvacević, R; Ignjatović, L; Jovanović, D; Karan, Z; Kovacević, Z; Maksić, D; Rabrenović, V; Tomić, A; Vavić, N1
Czaja, AJ1
Allen, L; Boyer, TD; Chatrath, H1
Hesselink, DA; van Gelder, T; van Schaik, RH1
Chan, TM1
Montero, N; Pascual, J1
Campistol, JM; Canha, C; Castells, A; Diekmann, F; Ferreira, R; Moya-Rull, D; Oppenheimer, F; Revuelta, I; Rovira, J1
Karam, S; Wali, RK1
Aleksiejuk, P; Banki, K; Bonilla, E; Francis, L; Landas, SK; Liu, Y; Marchena-Mendez, I; Oaks, Z; Patel, J; Perl, A; Yu, J1
Anglicheau, D; Babinet, F; Caillard, S; Colosio, C; Deslée, G; Dury, S; Essig, M; Etienne, I; Launois, C; Lebargy, F; Merieau, E; Perotin-Collard, JM; Rieu, P; Rivalan, J; Subra, JF; Thervet, E; Toubas, O1
Anderson, R; Bond, M; Coelho, H; Cooper, C; Crathorne, L; Dudley, J; Haasova, M; Huxley, N; Hyde, C; Jones-Hughes, T; Lowe, J; Marks, S; Mujica-Mota, R; Snowsill, T; Varley-Campbell, J1
Davidson, BR; Guerrero-Misas, M; Gurusamy, KS; Rodríguez-Perálvarez, M; Thorburn, D; Tsochatzis, E1
Almeida, RAMB; Calazans, CAC; Charpiot, IMMF; Costa, KMAH; Cristelli, MP; de Lima, PR; de Sandes-Freitas, TV; Deboni, LM; Ferreira, GF; Ferreira, TCA; Garcia, VD; Manfro, RC; Mazzali, M; Medina-Pestana, J; Modelli de Andrade, LG; Nakamura, MR; Oriá, RB; Pacheco-Silva, A; Requião-Moura, LR; Simão, DR; Tedesco-Silva, H; Viana, LA1
Camacho, I; Dave, Y; Eckembrecher, DG; Eckembrecher, FJ; Nouri, K; Patel, S; Shah, H1

Reviews

43 review(s) available for azathioprine and sirolimus

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation.
    Therapeutic immunology, 1994, Volume: 1, Issue:1

    Topics: Animals; Antimetabolites; Azathioprine; Biphenyl Compounds; Cell Differentiation; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocytes; Lymphokines; Oligonucleotides, Antisense; Polyenes; Receptors, Cytokine; Ribonucleosides; Signal Transduction; Sirolimus; Tacrolimus

1994
The monitoring of immunosuppressive drugs: a pharmacodynamic approach.
    Therapeutic drug monitoring, 1998, Volume: 20, Issue:5

    Topics: Azathioprine; Cyclosporine; Drug Monitoring; Humans; Immunosuppressive Agents; Methylprednisolone; Mycophenolic Acid; Sirolimus

1998
Progress with cyclosporine-sparing regimens.
    Transplantation proceedings, 1999, Volume: 31, Issue:8A

    Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Sirolimus; Transplantation, Homologous

1999
Pharmacological surrogates of allograft outcome.
    Annals of transplantation, 2000, Volume: 5, Issue:2

    Topics: Animals; Azathioprine; Cyclosporine; Drug Monitoring; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Sirolimus; Steroids; Tacrolimus; Transplantation, Homologous; Treatment Outcome

2000
Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:4 Suppl 2

    Topics: Adolescent; Age Factors; Azathioprine; Child; Child, Preschool; Clinical Trials as Topic; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Everolimus; Graft Rejection; Graft Survival; Half-Life; Humans; Immunosuppressive Agents; Intestinal Absorption; Kidney Transplantation; Prednisone; Sirolimus; Treatment Outcome

2001
Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
    Current opinion in rheumatology, 2003, Volume: 15, Issue:3

    Topics: Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rheumatic Diseases; Severity of Illness Index; Sirolimus; Tacrolimus; Transplants; Treatment Outcome

2003
Renal transplantation: basic concepts and evolution of therapy.
    Journal of clinical apheresis, 2003, Volume: 18, Issue:3

    Topics: Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Fingolimod Hydrochloride; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Receptors, Interleukin-2; Sirolimus; Sphingosine; Tacrolimus

2003
[Immunomodulation in penetrating keratoplasty. Current status and perspectives].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:12

    Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Animals; Antiviral Agents; Azathioprine; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Keratitis, Herpetic; Keratoplasty, Penetrating; Methotrexate; Mice; Multicenter Studies as Topic; Mycophenolic Acid; Pilot Projects; Prospective Studies; Risk Factors; Sirolimus; Tacrolimus

2003
Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants.
    The Annals of thoracic surgery, 2004, Volume: 77, Issue:1

    Topics: Adrenal Cortex Hormones; Antibodies; Azathioprine; Calcineurin Inhibitors; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus; Transplantation Immunology

2004
Steroid immunosuppression in kidney transplantation: a passing era.
    The Journal of surgical research, 2004, Volume: 117, Issue:1

    Topics: Adrenal Cortex Hormones; Azathioprine; Blood Pressure; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipid Metabolism; Sirolimus; Substance Withdrawal Syndrome; Transplantation Immunology

2004
Optimizing the immunosuppressive regimen in heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:5 Suppl

    Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Everolimus; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus

2004
Low toxicity immunosuppressive protocols in renal transplantation.
    The Keio journal of medicine, 2004, Volume: 53, Issue:1

    Topics: Azathioprine; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Prospective Studies; Random Allocation; Retrospective Studies; Sirolimus; Steroids; Tacrolimus; Time Factors; Treatment Outcome

2004
Immunosuppression and modulation in liver transplantation.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19 Suppl 4

    Topics: Azathioprine; Calcineurin Inhibitors; Glucocorticoids; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Living Donors; Mycophenolic Acid; Sirolimus; Tacrolimus

2004
Strategies to prevent chronic allograft nephropathy in kidney transplantation: focus on calcineurin inhibitors.
    Progress in transplantation (Aliso Viejo, Calif.), 2004, Volume: 14, Issue:2

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Patient Selection; Postoperative Care; Safety; Sirolimus; Tacrolimus; Transplantation, Homologous

2004
What is the calcineurin inhibitor of choice for pediatric renal transplantation?
    Pediatric transplantation, 2004, Volume: 8, Issue:5

    Topics: Azathioprine; Calcineurin Inhibitors; Child; Clinical Trials as Topic; Cyclosporine; Growth and Development; Hematologic Neoplasms; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Care; Sirolimus; Tacrolimus

2004
Immunosuppression: towards a logical approach in liver transplantation.
    Clinical and experimental immunology, 2005, Volume: 139, Issue:1

    Topics: Adrenal Cortex Hormones; Algorithms; Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cardiovascular Diseases; Graft Rejection; Humans; Immune Tolerance; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Sirolimus

2005
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
    Circulation, 2004, Dec-21, Volume: 110, Issue:25

    Topics: Administration, Oral; Adrenal Cortex Hormones; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Everolimus; Graft Rejection; Growth Inhibitors; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Protein Kinase Inhibitors; Protein Kinases; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation, Homologous

2004
Pharmacokinetics of immunosuppressants: a perspective on ethnic differences.
    International journal of clinical pharmacology and therapeutics, 2004, Volume: 42, Issue:12

    Topics: Azathioprine; Black People; Cyclosporine; Cytochrome P-450 Enzyme System; Everolimus; Graft Survival; Humans; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus; White People

2004
[Immunossupresive drugs in renal transplantation].
    Polskie Archiwum Medycyny Wewnetrznej, 2004, Volume: 112 Spec No

    Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Risk Factors; Rituximab; Sirolimus; Sphingosine; Tacrolimus

2004
From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:4 Suppl

    Topics: Azathioprine; Clinical Medicine; Clinical Trials as Topic; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Sirolimus; Transplantation, Homologous

2005
[Evidences in immunosuppression in the maintenance of renal transplantation].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2005, Volume: 25, Issue:4

    Topics: Adult; Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Meta-Analysis as Topic; Multicenter Studies as Topic; Mycophenolic Acid; Risk Factors; Sirolimus

2005
Review of major clinical trials with mycophenolate mofetil in renal transplantation.
    Transplantation, 2005, Oct-15, Volume: 80, Issue:2 Suppl

    Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Child; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Multicenter Studies as Topic; Mycophenolic Acid; Receptors, Interleukin-2; Sirolimus; Tacrolimus

2005
Malignancy after transplantation.
    Transplantation, 2005, Oct-15, Volume: 80, Issue:2 Suppl

    Topics: Azathioprine; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Mycophenolic Acid; Neoplasms; Sirolimus; Skin Neoplasms; Tacrolimus; Transplantation Immunology; Transplantation, Homologous

2005
Post-transplant de novo malignancies in renal transplant recipients: the past and present.
    Transplant international : official journal of the European Society for Organ Transplantation, 2006, Volume: 19, Issue:8

    Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Europe; Female; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Neoplasms; Ohio; Registries; Sirolimus; Tacrolimus; United States

2006
Calcineurin inhibitor-free protocols: risks and benefits.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2007, Volume: 18, Issue:1

    Topics: Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Patient Selection; Risk Assessment; Sirolimus; Treatment Outcome

2007
Proliferation signal inhibitors in cardiac transplantation.
    Current opinion in cardiology, 2007, Volume: 22, Issue:2

    Topics: Azathioprine; Calcineurin; Calcineurin Inhibitors; Cell Proliferation; Coronary Artery Disease; Dose-Response Relationship, Drug; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Signal Transduction; Sirolimus

2007
Immunosuppression for lung transplantation: evidence to date.
    Drugs, 2007, Volume: 67, Issue:11

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Mycophenolic Acid; Sirolimus; Tacrolimus

2007
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:2

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Pharmacogenetics; Polymorphism, Genetic; Sirolimus; Tacrolimus

2008
Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
    Transplantation proceedings, 2008, Volume: 40, Issue:10 Suppl

    Topics: Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Safety; Sirolimus; Treatment Outcome

2008
Management of chronic allograft nephropathy: a systematic review.
    Clinical journal of the American Society of Nephrology : CJASN, 2009, Volume: 4, Issue:4

    Topics: Azathioprine; Biopsy; Calcineurin Inhibitors; Chronic Disease; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Mycophenolic Acid; Sirolimus; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome

2009
Surgical biology for the clinician: vascular effects of immunosuppression.
    Canadian journal of surgery. Journal canadien de chirurgie, 2010, Volume: 53, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Cyclosporine; Delayed Graft Function; Endothelium, Vascular; Everolimus; Graft Rejection; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune Tolerance; Immunosuppressive Agents; Sirolimus; Tacrolimus; Transplantation Immunology

2010
Immunosuppressive therapy in children.
    Journal of the Indian Medical Association, 2011, Volume: 109, Issue:2

    Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nitriles; Sirolimus; Tacrolimus

2011
Effects of immunosuppressive therapy on wound healing.
    International wound journal, 2013, Volume: 10, Issue:1

    Topics: Animals; Azathioprine; Cyclosporine; Everolimus; Humans; Immunosuppressive Agents; Mycophenolic Acid; Rats; Sirolimus; Swine; Tacrolimus; Wound Healing; Wounds and Injuries

2013
Immunosuppression in HCV-positive liver-transplant recipients.
    Current opinion in organ transplantation, 2012, Volume: 17, Issue:6

    Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Daclizumab; Everolimus; Hepatitis C; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Mycophenolic Acid; Receptors, Interleukin-2; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases

2012
Current and prospective pharmacotherapy for autoimmune hepatitis.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:12

    Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Budesonide; Hepatitis, Autoimmune; Humans; Immunologic Factors; Immunosuppressive Agents; Liver; Mycophenolic Acid; Rituximab; Salvage Therapy; Sirolimus

2014
Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.
    Nature reviews. Nephrology, 2014, Volume: 10, Issue:12

    Topics: Azathioprine; Cyclosporine; Drug Monitoring; Everolimus; Evidence-Based Medicine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Organ Transplantation; Pharmacogenetics; Polymorphism, Genetic; Predictive Value of Tests; Sirolimus; Tacrolimus; Transplantation Immunology

2014
Treatment of severe lupus nephritis: the new horizon.
    Nature reviews. Nephrology, 2015, Volume: 11, Issue:1

    Topics: Antimalarials; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Ribonucleosides; Severity of Illness Index; Sirolimus; Tacrolimus

2015
Immunosuppression and Post-transplant Hyperglycemia.
    Current diabetes reviews, 2015, Volume: 11, Issue:3

    Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Everolimus; Graft Rejection; Humans; Hyperglycemia; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation

2015
Current State of Immunosuppression: Past, Present, and Future.
    Critical reviews in eukaryotic gene expression, 2015, Volume: 25, Issue:2

    Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal, Humanized; Azathioprine; Bone Marrow Transplantation; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Everolimus; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus

2015
Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Health technology assessment (Winchester, England), 2016, Volume: 20, Issue:61

    Topics: Abatacept; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Everolimus; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Models, Economic; Mycophenolic Acid; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; Technology Assessment, Biomedical

2016
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
    The Cochrane database of systematic reviews, 2017, Mar-31, Volume: 3

    Topics: Adult; Azathioprine; Bayes Theorem; Cyclosporine; Drug Therapy, Combination; Everolimus; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Retreatment; Sirolimus; Tacrolimus; Transplantation Immunology

2017
A review of heart transplant immunosuppressants and nonmelanoma skin cancer.
    Archives of dermatological research, 2023, Volume: 315, Issue:9

    Topics: Azathioprine; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus; Skin Neoplasms; Tacrolimus

2023

Trials

34 trial(s) available for azathioprine and sirolimus

ArticleYear
A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
    Transplantation proceedings, 1996, Volume: 28, Issue:2

    Topics: Adult; Aged; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Placebos; Polyenes; Prednisolone; Sirolimus

1996
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
    Lancet (London, England), 2000, Jul-15, Volume: 356, Issue:9225

    Topics: Acute Disease; Adolescent; Adult; Azathioprine; Biopsy; Cyclosporine; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Sirolimus; Survival Rate; Treatment Outcome

2000
Sirolimus steady-state trough concentrations are not affected by bolus methylprednisolone therapy in renal allograft recipients.
    British journal of clinical pharmacology, 2002, Volume: 54, Issue:1

    Topics: Adult; Azathioprine; Drug Combinations; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Sirolimus

2002
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study.
    Transplantation proceedings, 2003, Volume: 35, Issue:3 Suppl

    Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Drug Therapy, Combination; France; Graft Rejection; Hospitals, University; Humans; Hypercholesterolemia; Hypertriglyceridemia; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Prednisolone; Prednisone; Sirolimus

2003
Safety and efficacy of sirolimus in kidney transplant patients and in patients with coronary artery disease undergoing angioplasty.
    Transplantation proceedings, 2003, Volume: 35, Issue:3 Suppl

    Topics: Adult; Angioplasty, Balloon, Coronary; Azathioprine; Black People; Cadaver; Coronary Disease; Cyclosporine; Family; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Living Donors; Male; Risk Assessment; Safety; Sirolimus; Tissue Donors; Transplantation, Homologous

2003
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
    The New England journal of medicine, 2003, Aug-28, Volume: 349, Issue:9

    Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Lipids; Male; Middle Aged; Reoperation; Sirolimus; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional

2003
Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, Volume: 22, Issue:10

    Topics: Adrenal Cortex Hormones; Area Under Curve; Azathioprine; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Safety; Sirolimus

2003
An open-label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone combination.
    Clinical transplantation, 2004, Volume: 18, Issue:1

    Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Prednisone; Prospective Studies; Safety; Sirolimus

2004
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.
    Circulation, 2004, Oct-26, Volume: 110, Issue:17

    Topics: Acute Disease; Adult; Azathioprine; Coronary Artery Disease; Creatinine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Lipids; Sirolimus; Survival Analysis; Ultrasonography

2004
Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2004, Volume: 37, Issue:9

    Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Sirolimus; Treatment Outcome

2004
Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:12

    Topics: Azathioprine; Drug Monitoring; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Metabolic Clearance Rate; Prospective Studies; Reproducibility of Results; Sirolimus

2004
Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation.
    Clinical transplantation, 2005, Volume: 19, Issue:1

    Topics: Azathioprine; Clinical Trials as Topic; Cytomegalovirus Infections; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Prospective Studies; Sirolimus; Treatment Outcome

2005
Everolimus alters the bronchoalveolar lavage and endobronchial biopsy immunologic profile post-human lung transplantation.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:6

    Topics: Anti-Inflammatory Agents; Azathioprine; Bronchoalveolar Lavage; Bronchoscopy; Cytokines; Double-Blind Method; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphocyte Count; Male; Middle Aged; Placebos; Postoperative Complications; Prospective Studies; Sirolimus

2005
Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Everolimus; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung; Lung Transplantation; Male; Middle Aged; Sirolimus; Syndrome

2006
Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:4

    Topics: Adult; Area Under Curve; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Sirolimus; Treatment Outcome

2006
Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21 Suppl 3

    Topics: Azathioprine; Cardiovascular Diseases; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Heart Transplantation; Hospital Costs; Humans; Immunocompromised Host; Immunosuppressive Agents; Pennsylvania; Postoperative Complications; Risk Factors; Sirolimus; Tunica Intima; Ultrasonography

2006
Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients.
    Kidney international, 2006, Volume: 70, Issue:7

    Topics: Aged; Azathioprine; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Creatinine; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Proteinuria; Sirolimus; Skin Neoplasms; Time Factors

2006
Influence of everolimus on cyclosporine Neoral pharmacokinetics in Chinese de novo cardiac transplant recipients.
    Transplantation proceedings, 2006, Volume: 38, Issue:7

    Topics: Adult; Azathioprine; China; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Sirolimus

2006
Sirolimus attenuates the rate of progression of early chronic allograft nephropathy.
    Transplantation proceedings, 2006, Volume: 38, Issue:10

    Topics: Adult; Azathioprine; Biopsy; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Disease Progression; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Transplantation, Homologous; Treatment Outcome

2006
Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria.
    Transplantation proceedings, 2007, Volume: 39, Issue:3

    Topics: Aged; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Recombinant Fusion Proteins; Sirolimus

2007
Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007, Volume: 26, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cyclosporine; Double-Blind Method; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Middle Aged; Safety; Sirolimus; Transplantation, Homologous; Treatment Outcome

2007
Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007, Volume: 26, Issue:7

    Topics: Azathioprine; Biopsy; Bronchoalveolar Lavage; CD4-Positive T-Lymphocytes; Double-Blind Method; Everolimus; Female; Gene Expression Regulation; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-17; Lung; Lung Transplantation; Male; Middle Aged; Pneumonia; Prospective Studies; Sirolimus

2007
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.
    Circulation, 2007, Dec-04, Volume: 116, Issue:23

    Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous

2007
Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation.
    Transplantation proceedings, 2007, Volume: 39, Issue:10

    Topics: Acute Disease; Adult; Azathioprine; Belgium; Cardiomyopathy, Dilated; Coronary Disease; Cost of Illness; Double-Blind Method; Everolimus; Female; Graft Rejection; Heart Transplantation; Hemodynamics; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Survival Analysis; Treatment Failure

2007
A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
    The American journal of gastroenterology, 2008, Volume: 103, Issue:9

    Topics: Adolescent; Adult; Aged; Azathioprine; Crohn Disease; Double-Blind Method; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Placebos; Prospective Studies; Sirolimus; Statistics, Nonparametric; Steroids; Treatment Outcome

2008
Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression.
    Nephrology (Carlton, Vic.), 2009, Volume: 14, Issue:2

    Topics: Adult; Azathioprine; Costs and Cost Analysis; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Prospective Studies; Sirolimus

2009
Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.
    American journal of respiratory and critical care medicine, 2011, Feb-01, Volume: 183, Issue:3

    Topics: Azathioprine; Bronchiolitis Obliterans; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung Transplantation; Male; Middle Aged; Sirolimus; Tacrolimus; Time Factors

2011
Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2011, Volume: 30, Issue:2

    Topics: Azathioprine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Risk Factors; Sirolimus; Tacrolimus; Venous Thromboembolism

2011
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial.
    Transplantation, 2011, Jul-27, Volume: 92, Issue:2

    Topics: Aged; Azathioprine; C-Reactive Protein; Calcineurin Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Risk Factors; Scandinavian and Nordic Countries; Sirolimus; Ultrasonography, Interventional; Vascular Cell Adhesion Molecule-1; Vascular Diseases; von Willebrand Factor

2011
Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation.
    Transplantation, 2011, Sep-15, Volume: 92, Issue:5

    Topics: Adult; Azathioprine; Cyclosporine; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Postoperative Complications; Risk Factors; Sirolimus

2011
Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2011, Volume: 9, Issue:5

    Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Calcineurin Inhibitors; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Egypt; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Sirolimus; Steroids; Tacrolimus; Time Factors; Transplantation Conditioning; Treatment Outcome; Young Adult

2011
Platelet activation markers after conversion from azathioprine to sirolimus based immunosuppression in renal transplant recipients.
    International journal of clinical pharmacology and therapeutics, 2012, Volume: 50, Issue:12

    Topics: Adult; Aged; Azathioprine; CD11b Antigen; Female; Flow Cytometry; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Sirolimus

2012
Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Postoperative Complications; Sirolimus; Statistics as Topic

2013
Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:2

    Topics: Aged; Aged, 80 and over; Azathioprine; Calcineurin Inhibitors; Carcinoma, Squamous Cell; CD56 Antigen; Female; Forkhead Transcription Factors; Humans; Immune System; Immunosuppressive Agents; Kidney Transplantation; Killer Cells, Natural; Male; Middle Aged; Phenotype; Risk Factors; Single-Blind Method; Sirolimus; Skin Neoplasms; T-Lymphocytes; TOR Serine-Threonine Kinases; Transplantation

2013

Other Studies

68 other study(ies) available for azathioprine and sirolimus

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Cyclosporin A, FK506, rapamycin: the use of a quantitative analytic tool to discriminate immunosuppressive drug interactions.
    Journal of the American Society of Nephrology : JASN, 1992, Volume: 2, Issue:12 Suppl

    Topics: Animals; Azathioprine; Cyclosporine; Dexamethasone; DNA Replication; Dose-Response Relationship, Immunologic; Drug Interactions; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Mercaptopurine; Polyenes; Rats; Rats, Inbred BUF; Rats, Inbred WF; Sirolimus; Tacrolimus

1992
The effect of immunosuppressants on human leukocyte NADPH oxidase.
    Annals of the New York Academy of Sciences, 1994, Jun-17, Volume: 723

    Topics: Antigen-Presenting Cells; Azathioprine; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; In Vitro Techniques; Monocytes; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Polyenes; Sirolimus; Tacrolimus

1994
Myoblast allotransplantation in mice: degree of success varies depending on the efficacy of various immunosuppressive treatments.
    Transplantation proceedings, 1994, Volume: 26, Issue:6

    Topics: Animals; Azathioprine; Cyclosporine; Graft Survival; Immunosuppression Therapy; Immunosuppressive Agents; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscles; Muscular Dystrophy, Animal; Mycophenolic Acid; Polyenes; Sirolimus; Transplantation, Homologous

1994
Rapamycin in a porcine renal transplant model.
    Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 1

    Topics: Animals; Azathioprine; Biopsy; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immunosuppressive Agents; Kidney Transplantation; Polyenes; Prednisone; Sirolimus; Swine; Transplantation, Homologous

1993
Maintenance pharmacological immunosuppressive strategies in renal transplantation.
    Postgraduate medical journal, 1997, Volume: 73, Issue:861

    Topics: Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Polyenes; Postoperative Care; Sirolimus; Steroids; Tacrolimus

1997
Pharmacodynamic monitoring of immunosuppressive drugs.
    Clinical chemistry, 1998, Volume: 44, Issue:2

    Topics: Azathioprine; Calcineurin; Cyclosporine; Drug Monitoring; Graft vs Host Disease; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Methyltransferases; Mycophenolic Acid; Polyenes; Ribosomal Protein S6 Kinases; Sirolimus

1998
Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats.
    The Journal of trauma, 1998, Volume: 44, Issue:3

    Topics: Animals; Azathioprine; Cyclosporine; Drug Evaluation, Preclinical; Immunosuppressive Agents; Interleukin-16; Liver; Male; Neutrophils; Polyenes; Rats; Rats, Wistar; Reperfusion Injury; Sirolimus; Tacrolimus; Time Factors

1998
Effects of rapamycin analogue SDZ RAD on obliterative lesions in a porcine heterotopic bronchial allograft model.
    Transplantation proceedings, 1998, Volume: 30, Issue:5

    Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cartilage; Cyclosporine; Epithelium; Everolimus; Immunosuppressive Agents; Methylprednisolone; Mucous Membrane; Necrosis; Polyenes; Sirolimus; Swine; Transplantation, Heterotopic; Transplantation, Homologous

1998
Hypertriglyceridemia in renal transplant recipients treated with sirolimus.
    Transplantation proceedings, 1998, Volume: 30, Issue:8

    Topics: Adult; Aged; Azathioprine; Cholesterol; Drug Therapy, Combination; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Prednisolone; Sirolimus; Triglycerides

1998
A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.
    Transplant immunology, 1999, Volume: 7, Issue:3

    Topics: Animals; Azathioprine; Cell Division; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; In Vitro Techniques; Islets of Langerhans Transplantation; Leukocytes, Mononuclear; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Methylprednisolone; Mycophenolic Acid; Phytohemagglutinins; Sirolimus; Species Specificity; Swine; Tacrolimus; Transplantation, Homologous

1999
Prevention of small airway obliteration in a swine heterotopic lung allograft model.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2000, Volume: 19, Issue:2

    Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Disease Models, Animal; Epithelium; Everolimus; Graft Rejection; Immunosuppressive Agents; Lung Transplantation; Postoperative Complications; Sirolimus; Swine; Transplantation, Heterotopic; Transplantation, Homologous

2000
A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levels.
    Transplantation proceedings, 2000, Volume: 32, Issue:4

    Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Period; Predictive Value of Tests; Prednisone; Sirolimus; Time Factors

2000
Sirolimus vs azathioprine.
    Lancet (London, England), 2000, Nov-18, Volume: 356, Issue:9243

    Topics: Azathioprine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Sirolimus

2000
Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia.
    Transplantation proceedings, 2000, Volume: 32, Issue:8

    Topics: Adult; Apolipoprotein C-III; Apolipoproteins A; Apolipoproteins B; Apolipoproteins C; Azathioprine; Calcineurin Inhibitors; Cholesterol; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Reference Values; Sirolimus; Tacrolimus; Triglycerides

2000
Immune cells and immunosuppression in a porcine bronchial model of obliterative bronchiolitis.
    Transplantation, 2001, Sep-27, Volume: 72, Issue:6

    Topics: Animals; Azathioprine; Bronchi; Bronchiolitis; Cyclosporine; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Immune System; Immunohistochemistry; Immunosuppression Therapy; Immunosuppressive Agents; Methylprednisolone; Sirolimus; Swine; Time Factors; Transplantation Immunology; Transplantation, Autologous; Transplantation, Homologous

2001
Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.
    Transplantation proceedings, 2002, Volume: 34, Issue:4

    Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Reoperation; Retrospective Studies; Risk Factors; Sirolimus; Steroids; Treatment Failure

2002
Sirolimus: new preparation. No tangible advance in renal transplantation.
    Prescrire international, 2002, Volume: 11, Issue:62

    Topics: Azathioprine; Clinical Trials as Topic; Cyclosporine; Drug Approval; Drug Therapy, Combination; Europe; Graft Rejection; Humans; Hyperlipidemias; Hypokalemia; Immunosuppressive Agents; Kidney Transplantation; Sirolimus; Thrombocytopenia; United States; United States Food and Drug Administration

2002
[To further improve transplantation results].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2002, Volume: 73, Issue:12

    Topics: Azathioprine; Cyclosporine; Double-Blind Method; Everolimus; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Monitoring, Physiologic; Multicenter Studies as Topic; Organ Transplantation; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome

2002
Use of sirolimus to facilitate cyclosporine avoidance or steroid withdrawal in kidney transplant recipients.
    Transplantation proceedings, 2003, Volume: 35, Issue:3 Suppl

    Topics: Adrenal Cortex Hormones; Azathioprine; Cell Cycle; Creatinine; Cyclosporine; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Sirolimus; Time Factors

2003
Cardiac-allograft vasculopathy.
    The New England journal of medicine, 2003, Aug-28, Volume: 349, Issue:9

    Topics: Azathioprine; Coronary Disease; Cytomegalovirus Infections; Drug Therapy, Combination; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Sirolimus

2003
Everolimus in cardiac-transplant recipients.
    The New England journal of medicine, 2003, Dec-04, Volume: 349, Issue:23

    Topics: Azathioprine; Coronary Disease; Coronary Vessels; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Sirolimus

2003
The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
    Transplantation, 2003, Dec-27, Volume: 76, Issue:12

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus; Time Factors; Wound Healing

2003
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
    Transplantation, 2004, Jan-27, Volume: 77, Issue:2

    Topics: Adult; Aged; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cell Division; Cells, Cultured; Cyclosporine; Everolimus; Female; Fibroblasts; Humans; Immunosuppressive Agents; Infections; Lung Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus

2004
Is everolimus useful in preventing allograft rejection and vasculopathy after heart transplant?
    Expert opinion on investigational drugs, 2004, Volume: 13, Issue:2

    Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Creatinine; Cyclosporins; Drug Therapy, Combination; Everolimus; Graft Rejection; Heart Transplantation; Humans; Middle Aged; Multicenter Studies as Topic; Peripheral Vascular Diseases; Sirolimus; Transplantation, Homologous

2004
[Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2004, Volume: 24 Suppl 3

    Topics: Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diagnosis, Differential; Diuretics; Doxazosin; Drug Therapy, Combination; Famotidine; Furosemide; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Interstitial; Male; Muscular Diseases; Mycophenolic Acid; Pneumonia, Bacterial; Postoperative Complications; Prednisone; Sirolimus

2004
Everolimus-induced drug fever after heart transplantation.
    Transplantation, 2004, Jul-27, Volume: 78, Issue:2

    Topics: Aged; Azathioprine; Cardiomyopathy, Dilated; Drug Therapy, Combination; Everolimus; Fever; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Sirolimus

2004
Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
    Pediatric transplantation, 2004, Volume: 8, Issue:5

    Topics: Acute Disease; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Daclizumab; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Sirolimus; Tacrolimus; Treatment Outcome

2004
Cyclooxygenase-2 expression in experimental post-transplant obliterative bronchiolitis.
    The Journal of pathology, 2004, Volume: 204, Issue:3

    Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Chondrocytes; Cyclooxygenase 2; Cyclosporine; Disease Models, Animal; Epithelial Cells; Everolimus; Fibroblasts; Fibrosis; Immunohistochemistry; Immunosuppressive Agents; Isoenzymes; Macrophages; Methylprednisolone; Postoperative Period; Prostaglandin-Endoperoxide Synthases; Sirolimus; Swine

2004
Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:4 Suppl

    Topics: Adult; Angioplasty, Balloon, Coronary; Azathioprine; Clinical Trials, Phase III as Topic; Coronary Disease; Coronary Vessels; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional

2005
Rapamycin successfully treats post-transplant autoimmune hepatitis.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:5

    Topics: Autoantibodies; Azathioprine; Biopsy; Calcineurin Inhibitors; Child; Child, Preschool; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Infant; Infant, Newborn; Liver; Liver Diseases; Male; Mycophenolic Acid; Postoperative Complications; Prednisolone; Sirolimus; Time Factors; Transaminases; Treatment Outcome

2005
Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen.
    Transplantation, 2005, Apr-27, Volume: 79, Issue:8

    Topics: Adoptive Transfer; Animals; Azathioprine; CD4-Positive T-Lymphocytes; Cyclosporine; Dendritic Cells; Graft Survival; Immunosuppression Therapy; Immunosuppressive Agents; Interleukin-2; Isoantigens; Mice; Mycophenolic Acid; Sirolimus; Spleen; Tacrolimus; Time Factors; Tissue Donors; Trachea; Transplantation

2005
Therapeutic drug monitoring for everolimus in heart transplant recipients: flawed model or a model for future use?
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:9

    Topics: Azathioprine; Biopsy; Drug Monitoring; Drug Therapy, Combination; Everolimus; Glomerular Filtration Rate; Heart Transplantation; Humans; Immunosuppressive Agents; Metabolic Clearance Rate; Mycophenolic Acid; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography

2005
Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2006, Volume: 39, Issue:1

    Topics: Adult; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperlipidemias; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lipid Metabolism; Male; Prednisone; Severity of Illness Index; Sirolimus; Time Factors

2006
Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.
    Transplantation proceedings, 2006, Volume: 38, Issue:5

    Topics: Adult; Aged; Azathioprine; Blood Urea Nitrogen; Calcineurin Inhibitors; Creatinine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous

2006
Conversion to a proliferation signal inhibitor in a patient with coronary artery disease--a case report.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21 Suppl 3

    Topics: Angina Pectoris; Angioplasty; Azathioprine; Calcineurin Inhibitors; Cell Proliferation; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Signal Transduction; Sirolimus; Treatment Outcome; Withholding Treatment

2006
Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone.
    Transplantation, 2007, Mar-27, Volume: 83, Issue:6

    Topics: Actins; Azathioprine; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclosporine; Epithelial Cells; Fibroblasts; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules, Proximal; Methylprednisolone; Mycophenolic Acid; Sirolimus; Transforming Growth Factor beta; Versicans

2007
Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation.
    Transplantation proceedings, 2007, Volume: 39, Issue:3

    Topics: Adrenal Cortex Hormones; Azathioprine; Cryptogenic Organizing Pneumonia; Cyclosporine; Everolimus; Female; Humans; Kidney Transplantation; Methylprednisolone; Middle Aged; Papillomavirus Infections; Polycystic Kidney Diseases; Postoperative Complications; Sirolimus; Vaginal Neoplasms

2007
[Lymphocele and kidney transplantation].
    Orvosi hetilap, 2007, Aug-05, Volume: 148, Issue:31

    Topics: Adult; Azathioprine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphocele; Male; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Severity of Illness Index; Sirolimus

2007
Sirolimus and cardiac transplantation: is it the "magic bullet"?
    Circulation, 2007, Dec-04, Volume: 116, Issue:23

    Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous

2007
Novel methods for tracking long-term maintenance immunosuppression regimens.
    Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:1

    Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Data Collection; Enzyme Inhibitors; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Medical Records Systems, Computerized; Medicare; Mycophenolic Acid; Pharmacies; Prevalence; Sirolimus; Tissue and Organ Procurement; United States

2008
Posttransplantation conversion to sirolimus-based immunosuppression: a single center experience.
    Transplantation proceedings, 2007, Volume: 39, Issue:10

    Topics: Azathioprine; Drug Therapy, Combination; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus; Tacrolimus; Treatment Outcome

2007
Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:1

    Topics: Area Under Curve; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Antagonism; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Sirolimus; Tacrolimus

2008
Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
    Nephrology (Carlton, Vic.), 2008, Volume: 13, Issue:2

    Topics: Administration, Oral; Adult; Antibodies; Antimetabolites; Australia; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Everolimus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; New Zealand; Practice Patterns, Physicians'; Prednisolone; Protein Kinases; Registries; Sirolimus; Steroids; Tacrolimus; Time Factors; TOR Serine-Threonine Kinases

2008
Pericardial effusion coincident with sirolimus therapy: a review of Wyeth's safety database.
    Transplantation, 2008, Feb-27, Volume: 85, Issue:4

    Topics: Azathioprine; Cardiac Tamponade; Databases, Factual; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Pericardial Effusion; Sirolimus

2008
Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2008, Volume: 27, Issue:10

    Topics: Administration, Oral; Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cell Division; Everolimus; Glomerular Filtration Rate; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Kidney Function Tests; Renal Insufficiency; Retrospective Studies; Sirolimus

2008
Rapamycin instead of mycophenolate mofetil or azathioprine in treatment of post-renal transplantation urothelial carcinoma.
    Chinese medical journal, 2009, Jan-05, Volume: 122, Issue:1

    Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Urinary Bladder Neoplasms; Urothelium

2009
Mucosa-associated lymphoid tissue gastric lymphoma regression in a renal transplant patient after conversion of the immunosuppression to sirolimus: a case report.
    Transplantation proceedings, 2009, Volume: 41, Issue:3

    Topics: Adult; Azathioprine; Cyclosporine; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Lymphoma, B-Cell, Marginal Zone; Sirolimus; Stomach Neoplasms

2009
Long-term follow-up of 100 high-risk renal transplant recipients converted from calcineurin inhibitors to sirolimus: a single center experience.
    Transplantation proceedings, 2009, Volume: 41, Issue:5

    Topics: Adult; Azathioprine; Calcineurin Inhibitors; Creatinine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Intracranial Hypertension; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus; Survival Analysis; Young Adult

2009
Pulmonary toxicity associated with sirolimus following kidney transplantation: computed tomography findings.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2010, Volume: 30, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Metronidazole; Mycophenolic Acid; Pneumonia; Pneumonia, Bacterial; Pneumonia, Viral; Postoperative Complications; Sirolimus; Tacrolimus; Tomography, X-Ray Computed

2010
Sirolimus addition to tacrolimus-based immunosuppression induces complete remission of post-transplant lymphoproliferative disorder in a liver transplant recipient.
    Transplant international : official journal of the European Society for Organ Transplantation, 2010, Volume: 23, Issue:10

    Topics: Azathioprine; Female; Humans; Immunosuppression Therapy; Liver Transplantation; Lymphoma, Large B-Cell, Diffuse; Sirolimus; Steroids; Tacrolimus; Young Adult

2010
Bone disease in renal transplantation and pleotropic effects of vitamin D therapy.
    Transplantation proceedings, 2010, Volume: 42, Issue:7

    Topics: Azathioprine; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Creatinine; Female; Humans; Kidney Transplantation; Lipids; Male; Methylprednisolone; Mycophenolic Acid; Osteonecrosis; Osteoporosis; Sirolimus; Vitamin D

2010
Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal.
    Transplantation proceedings, 2010, Volume: 42, Issue:9

    Topics: Adolescent; Adult; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Germany; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Skin Neoplasms; Survival Rate; Time Factors; TOR Serine-Threonine Kinases; Transplantation, Homologous; Treatment Outcome; Young Adult

2010
Tailoring immunosuppressive therapy for lung transplantation: moving beyond hand-me-down data.
    American journal of respiratory and critical care medicine, 2011, Feb-01, Volume: 183, Issue:3

    Topics: Azathioprine; Humans; Immunosuppressive Agents; Lung Transplantation; Randomized Controlled Trials as Topic; Sirolimus

2011
Everolimus for cardiac allograft vasculopathy--every patient, at any time?
    Transplantation, 2011, Jul-27, Volume: 92, Issue:2

    Topics: Azathioprine; Calcineurin Inhibitors; Cell Proliferation; Disease Progression; Drug Therapy, Combination; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Muscle, Smooth, Vascular; Mycophenolic Acid; Risk Factors; Sirolimus; Vascular Diseases

2011
Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan.
    Transplantation proceedings, 2012, Volume: 44, Issue:1

    Topics: Adult; Ambulatory Care; Azathioprine; Cyclosporine; Drug Costs; Drug Therapy, Combination; Drug Utilization; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Practice Patterns, Physicians'; Prednisolone; Sirolimus; Tacrolimus; Taiwan; Time Factors; Treatment Outcome

2012
Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database.
    Transplantation proceedings, 2012, Volume: 44, Issue:1

    Topics: Azathioprine; Cyclosporine; Databases as Topic; Drug Therapy, Combination; Drug Utilization; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; National Health Programs; Practice Patterns, Physicians'; Sirolimus; Tacrolimus; Taiwan; Time Factors; Treatment Outcome

2012
Successful resolution of inflammation and increased regulatory T cells in sirolimus-treated post-transplant allograft hepatitis.
    Pediatric transplantation, 2012, Volume: 16, Issue:2

    Topics: Azathioprine; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis; Humans; Immunosuppressive Agents; Infant; Liver; Liver Transplantation; Male; Postoperative Complications; Prednisone; Retrospective Studies; Single-Blind Method; Sirolimus; T-Lymphocytes, Regulatory; Tacrolimus; Treatment Outcome

2012
Cancer after heart transplant: implications for practice.
    Progress in transplantation (Aliso Viejo, Calif.), 2012, Volume: 22, Issue:4

    Topics: Azathioprine; Carcinoma, Squamous Cell; Drug Therapy, Combination; Fatal Outcome; Glucocorticoids; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Pleural Neoplasms; Prednisone; Sirolimus; Skin Neoplasms; Tacrolimus

2012
Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment.
    Gut, 2014, Volume: 63, Issue:3

    Topics: Animals; Autoimmune Diseases; Azathioprine; Biomarkers; Cell Proliferation; CTLA-4 Antigen; Cyclosporine; Dexamethasone; Drug Administration Schedule; Female; Flow Cytometry; Immunosuppressive Agents; Lymphocyte Activation; Mice; Mice, Inbred Strains; Pancreas; Pancreatitis, Chronic; Poly I-C; Random Allocation; Sirolimus; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Treatment Outcome

2014
Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:6

    Topics: Antibodies, Viral; Azathioprine; Brazil; Cyclosporine; Female; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Kidney Transplantation; Male; Mycophenolic Acid; Pandemics; Prospective Studies; Risk Factors; Sex Factors; Sirolimus; Tacrolimus; White People

2013
Conversion from calcineurin inhibitors to sirolimus of recipients with chronic kidney graft disease grade III for a period 2003-2011.
    Vojnosanitetski pregled, 2013, Volume: 70, Issue:9

    Topics: Adult; Azathioprine; Biomarkers; Calcineurin Inhibitors; Creatinine; Cytomegalovirus Infections; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Renal Insufficiency, Chronic; Sirolimus; Time Factors; Treatment Outcome

2013
Use of sirolimus in the treatment of refractory autoimmune hepatitis.
    The American journal of medicine, 2014, Volume: 127, Issue:11

    Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Drug Resistance; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Mycophenolic Acid; Prednisone; Sirolimus; Young Adult

2014
A case of esophageal adenocarcinoma on long-term rapamycin monotherapy.
    Transplant international : official journal of the European Society for Organ Transplantation, 2015, Volume: 28, Issue:10

    Topics: Adenocarcinoma; Aged; Azathioprine; Biomarkers; Cyclosporine; Drug Substitution; Esophageal Neoplasms; Esophagectomy; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Neoplasm Proteins; Neoplasms, Second Primary; Phosphorylation; Postoperative Complications; Prednisone; Protein Processing, Post-Translational; Sarcoma, Kaposi; Signal Transduction; Sirolimus; Skin Neoplasms; TOR Serine-Threonine Kinases

2015
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
    Clinical immunology (Orlando, Fla.), 2015, Volume: 160, Issue:2

    Topics: Acetylcysteine; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotransferases; Azathioprine; Biomarkers; Cohort Studies; Complement System Proteins; Cyclosporine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Liver Diseases; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prevalence; Retrospective Studies; Severity of Illness Index; Sex Distribution; Sirolimus

2015
Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.
    BMC pulmonary medicine, 2015, Nov-07, Volume: 15

    Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Azathioprine; Bronchiectasis; Chronic Disease; Cough; Cyclosporine; Everolimus; Female; Forced Expiratory Volume; Graft Rejection; Haemophilus Infections; Haemophilus influenzae; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Polycystic Kidney, Autosomal Dominant; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Rituximab; Sirolimus; Tacrolimus; Tomography, X-Ray Computed; Vital Capacity; Young Adult

2015
The Mycophenolate-based Immunosuppressive Regimen Is Associated With Increased Mortality in Kidney Transplant Patients With COVID-19.
    Transplantation, 2022, 10-01, Volume: 106, Issue:10

    Topics: Azathioprine; Calcineurin Inhibitors; COVID-19; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Sirolimus; TOR Serine-Threonine Kinases

2022